These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 2908545

  • 1. [Continuous dopaminergic stimulation in Parkinson disease].
    Obeso JA, Luquin MR, Vaamonde J, Grandas F, Pastor MA, Artieda J, Martínez-Lage JM.
    Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
    [No Abstract] [Full Text] [Related]

  • 2. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J, Luquin MR, Obeso JA.
    Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
    [Abstract] [Full Text] [Related]

  • 3. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
    Agnoli A, Stocchi F, Carta A, Antonini A, Bragoni M, Ruggieri SA.
    Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
    [No Abstract] [Full Text] [Related]

  • 4. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A.
    Mov Disord; 1988 Jan; 3(4):313-9. PubMed ID: 3211176
    [Abstract] [Full Text] [Related]

  • 5. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
    Rinne UK.
    Arch Neurobiol (Madr); 1991 Jan; 54(6):282-7. PubMed ID: 1687430
    [No Abstract] [Full Text] [Related]

  • 6. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
    Titova NV, Katunina EA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013 Jan; 113(12):105-12. PubMed ID: 24596973
    [No Abstract] [Full Text] [Related]

  • 7. Dopaminergic agonists in the treatment of Parkinson's disease.
    Goetz CG, Diederich NJ.
    Neurol Clin; 1992 May; 10(2):527-40. PubMed ID: 1350052
    [Abstract] [Full Text] [Related]

  • 8. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 Aug 09; 2(8502):348-9. PubMed ID: 2874360
    [No Abstract] [Full Text] [Related]

  • 9. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
    Stocchi F, Ruggieri S, Antonini A, Baronti F, Brughitta G, Bellantuono P, Bravi D, Agnoli A.
    J Neural Transm Suppl; 1988 Aug 09; 27():27-33. PubMed ID: 3165437
    [Abstract] [Full Text] [Related]

  • 10. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T, Giovannini P, Parati E, Scigliano G, Grassi MP, Carella F.
    Adv Neurol; 1984 Aug 09; 40():531-5. PubMed ID: 6695632
    [No Abstract] [Full Text] [Related]

  • 11. Lisuride infusion pump in Parkinson's disease. A report of two cases.
    Gershanik OS, Scipioni O, García S.
    J Neural Transm Suppl; 1988 Aug 09; 27():85-90. PubMed ID: 2969955
    [Abstract] [Full Text] [Related]

  • 12. Lisuride combined with levodopa in advanced Parkinson disease.
    Lieberman AN, Goldstein M, Leibowitz M, Neophytides A, Gopinathan G, Walker R, Pact V.
    Neurology; 1981 Nov 09; 31(11):1466-9. PubMed ID: 7031504
    [Abstract] [Full Text] [Related]

  • 13. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
    Obeso JA, Luquin MR, Martínez Lage JM.
    Ann Neurol; 1986 Jan 09; 19(1):31-5. PubMed ID: 3947037
    [Abstract] [Full Text] [Related]

  • 14. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
    Bittkau S, Przuntek H.
    J Neural Transm Suppl; 1988 Jan 09; 27():35-54. PubMed ID: 3165438
    [Abstract] [Full Text] [Related]

  • 15. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
    Piccinin GL, Piccirilli M, Rizzo PA, Agostini L.
    Clin Ter; 1983 Mar 31; 104(6):469-71. PubMed ID: 6851447
    [No Abstract] [Full Text] [Related]

  • 16. Psychosis and the lisuride pump.
    Critchley P, Grandas Perez F, Quinn N, Coleman R, Parkes D, Marsden CD.
    Lancet; 1986 Aug 09; 2(8502):349. PubMed ID: 2874361
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
    Stocchi F, Ruggieri S, Brughitta G, Agnoli A.
    J Neural Transm Suppl; 1986 Aug 09; 22():209-18. PubMed ID: 3465872
    [Abstract] [Full Text] [Related]

  • 20. [Oral lisuride in Parkinson's disease].
    Obeso JA, Luquin MR, Martínez Lage JM.
    Med Clin (Barc); 1985 Sep 21; 85(8):307-12. PubMed ID: 4068822
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.